These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10518586)

  • 1. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.
    Corti O; Sánchez-Capelo A; Colin P; Hanoun N; Hamon M; Mallet J
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12120-5. PubMed ID: 10518586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
    Horellou P; Vigne E; Castel MN; Barnéoud P; Colin P; Perricaudet M; Delaère P; Mallet J
    Neuroreport; 1994 Dec; 6(1):49-53. PubMed ID: 7703427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease.
    Azzouz M; Martin-Rendon E; Barber RD; Mitrophanous KA; Carter EE; Rohll JB; Kingsman SM; Kingsman AJ; Mazarakis ND
    J Neurosci; 2002 Dec; 22(23):10302-12. PubMed ID: 12451130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
    Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
    Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector.
    Georgievska B; Jakobsson J; Persson E; Ericson C; Kirik D; Lundberg C
    Hum Gene Ther; 2004 Oct; 15(10):934-44. PubMed ID: 15585109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.
    Mandel RJ; Rendahl KG; Spratt SK; Snyder RO; Cohen LK; Leff SE
    J Neurosci; 1998 Jun; 18(11):4271-84. PubMed ID: 9592104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitors.
    Corti O; Sabaté O; Horellou P; Colin P; Dumas S; Buchet D; Buc-Caron MH; Mallet J
    Nat Biotechnol; 1999 Apr; 17(4):349-54. PubMed ID: 10207882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopa-producing astrocytes generated by adenoviral transduction of human tyrosine hydroxylase gene: in vitro study and transplantation to hemiparkinsonian model rats.
    Hida H; Hashimoto M; Fujimoto I; Nakajima K; Shimano Y; Nagatsu T; Mikoshiba K; Nishino H
    Neurosci Res; 1999 Nov; 35(2):101-12. PubMed ID: 10616914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease.
    Cederfjäll E; Sahin G; Kirik D; Björklund T
    Mol Ther; 2012 Jul; 20(7):1315-26. PubMed ID: 22294150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
    Leff SE; Rendahl KG; Spratt SK; Kang UJ; Mandel RJ
    Exp Neurol; 1998 Jun; 151(2):249-64. PubMed ID: 9628761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease.
    Cederfjäll E; Broom L; Kirik D
    Mol Ther; 2015 May; 23(5):896-906. PubMed ID: 25592335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of dopamine-secretion by Tet-Off system in an in vivo model of parkinsonian rat.
    Kobayashi K; Yasuhara T; Agari T; Muraoka K; Kameda M; Ji Yuan W; Hayase H; Matsui T; Miyoshi Y; Shingo T; Date I
    Brain Res; 2006 Aug; 1102(1):1-11. PubMed ID: 16806124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
    Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline-regulated co-expression of GDNF and TH in PC12 cells.
    Wang JJ; Zhang T; Niu DB; Wang K; Li KR; Xue B; Wang XM
    Neurosci Lett; 2006 Jun; 401(1-2):142-5. PubMed ID: 16584838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase.
    During MJ; Naegele JR; O'Malley KL; Geller AI
    Science; 1994 Nov; 266(5189):1399-403. PubMed ID: 7669103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.